(Q45051950)

8 December 2017

title

Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina (English)

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

27 October 2022

1 reference

F. Akhras

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681355

27 October 2022

G. Jackson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1681355

27 October 2022

language of work or name

English

0 references

publication date

1 October 1991

1 reference

8 December 2017

26 October 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1681355

full work available at URL

27 October 2022

https://api.elsevier.com/content/article/PII:014067369191900F?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

https://api.elsevier.com/content/article/PII:014067369191900F?httpAccept=text/plain

27 October 2022

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

27 October 2022

1 reference

8 December 2017

volume

338

1 reference

8 December 2017

issue

8774

1 reference

8 December 2017

page(s)

1036-1039

1 reference

Propranolol and isosorbide dinitrate synergism in angina pectoris

8 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

27 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina

27 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

Propranolol in patients with angina pectoris.

27 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

Propranolol and angina pectoris.

27 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function

27 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol

27 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.

27 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

Addition of nifedipine to maximal beta-blocker-nitrate therapy: effects on exercise capacity and global left ventricular performance at rest and during exercise

27 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

"Maximal" drug therapy is not necessarily optimal in chronic angina pectoris

27 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0140-6736(91)91900-F

27 October 2022

Identifiers

1 reference

8 December 2017

1 reference